ObvioHealth Announces Next Generation Virtual Research Platform and Ecosystem
Seamless integration of ObvioHealth patient-friendly app with digital device partners enables frictionless remote monitoring of patient vitals from home
News provided by
Share this article
Share this article
NEW YORK, Feb. 16, 2021 /PRNewswire/ ObvioHealth, a global Virtual Research Organization (VRO), announces its next generation platform offering enhanced remote patient monitoring capabilities for the company s end-to-end decentralized clinical trial solutions.
ObvioHealth s decentralized platform and smartphone app have been designed from inception with patients in mind. To date, dozens of ObvioHealth virtual trials have delivered best in class metrics for patient recruitment time, medication adherence and retention. The platform upgrade builds on this momentum, integrating an ecosystem of FDA-cleared devices to support remote monitoring through seamless connections to its patient-centric app.
/PRNewswire/ ObvioHealth, a global virtual research organization (VRO), and GI Alliance, one of the nation s largest independent gastroenterology services.